Abstract:The reduction of excessive weight remains a major public health challenge, with control currently limited to a calorie reduction strategy. Currently, attempts are being made at revisiting the fibre hypothesis based on the African studies of Denis Burkitt, that the lack of dietary fibre in the modern diet was responsible for the occurrence of obesity and many of the other non-communicable diseases of what he called “Western civilization”. However, the dilemma is that Burkitt himself stressed that other peoples of his day, such as the Maasai, remained healthy without consuming such high fibre diets. Equally, the present obesity epidemic is accompanied by diseases of a malfunctioning immune system and of poor mental health that do not seem to be adequately explained simply by a deficiency of dietary fibre. Though unknown in Burkitt’s day, an increasing degradation of a mutualistic intestinal microbiome would offer a better fit to the observed epidemiology, especially if the microbiome is not effectively passed on from mother to child at birth. Taking the broader view, in this article we posit a view of the microbiome as a cofactor of mammalian evolution, in which a maternal microbial inheritance complements the parental genetic inheritance of the animal, both engaging epigenetic processes. As this would require the microbiome to be fully integrated with the animal as it develops into an adult, so we have a meaningful evolutionary role for the microbiome–gut–brain axis. By a failure to correctly establish a microbiome–gut interface, the inhibition of maternal microbial inheritance sets the scene for the future development of non-communicable disease: compromised immune system function on the one hand and dysfunctional gut–brain communication on the other. The basic principle is that the fully functioning, diverse, microbiome achieves interkingdom communication by the generation of messenger chemicals, semiochemicals. It is envisaged that the in situ detection of these as yet ill-defined chemical entities by means of an ingestible sensor would indicate the severity of disease and provide a guide as to its amelioration.

The gut microbiota in obesity and weight management: microbes as friends or foe?

Microbiome–Gut Dissociation: Investigating the Origins of Obesity

Understanding the role of the human gut microbiome in overweight and obesity

Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities

Talking microbes: When gut bacteria interact with diet and host organs

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

Commensal Homeostasis of Gut Microbiota-Host for the Impact of Obesity

The gut microbiota, obesity and insulin resistance

Gut microbiota in obesity and metabolic disorders

Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics

Gut Microbiota Interventions for the Management of Obesity: A Literature Review

Exploring the Impact of the Gut Microbiome on Obesity and Weight Loss: A Review Article

The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease

Gut Microbiome Modulation Based on Probiotic Application for Anti-Obesity: A Review on Efficacy and Validation

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight

The microbiome's influence on obesity: mechanisms and therapeutic potential

Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review

Importance of gut microbiota in obesity

Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?

The critical role of gut microbiota in obesity